Files

GBD_2017_Non-Typhoidal_Salmonella_Invasive_Disease_Collaborators_Lancet_Infect_Dis_2019.pdf (1.65 MB)

Document type

Article

Version

Published version

Publication date

2019-09-24

Publication license

cc by (c) Stanaway et al., 2019
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/143462

The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.1016/S1473-3099(19)30418-9

Abstract

Background: Non-typhoidal salmonella invasive disease is a major cause of global morbidity and mortality. Malnourished children, those with recent malaria or sickle-cell anaemia, and adults with HIV infection are at particularly high risk of disease. We sought to estimate the burden of disease attributable to non-typhoidal salmonella invasive disease for the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017. Methods: We did a systematic review of scientific databases and grey literature, and estimated non-typhoidal salmonella invasive disease incidence and mortality for the years 1990 to 2017, by age, sex, and geographical location using DisMod-MR, a Bayesian meta-regression tool. We estimated case fatality by age, HIV status, and sociodemographic development. We also calculated the HIV-attributable fraction and estimated health gap metrics, including disabilityadjusted life-years (DALYs). Findings: We estimated that 535 000 (95% uncertainty interval 409000–705000) cases of non-typhoidal salmonella invasive disease occurred in 2017, with the highest incidence in sub-Saharan Africa (34·5 [26·6–45·0] cases per 100000 person-years) and in children younger than 5 years (34·3 [23·2–54·7] cases per 100000 person-years). 77 500 (46400–123000) deaths were estimated in 2017, of which 18 400 (12000–27 700) were attributable to HIV. The remaining 59 100 (33300–98 100) deaths not attributable to HIV accounted for 4·26 million (2·38–7·38) DALYs in 2017. Mean all-age case fatality was 14·5% (9·2–21·1), with higher estimates among children younger than 5 years (13·5% [8·4–19·8]) and elderly people (51·2% [30·2–72·9] among those aged ≥70 years), people with HIV infection (41·8% [30·0–54·0]), and in areas of low sociodemographic development (eg, 15·8% [10·0–22·9] in sub-Saharan Africa). Interpretation: We present the first global estimates of non-typhoidal salmonella invasive disease that have been produced as part of GBD 2017. Given the high disease burden, particularly in children, elderly people, and people with HIV infection, investigating the sources and transmission pathways of non-typhoidal salmonella invasive disease is crucial to implement effective preventive and control measures.

Subject

Salmonel·la, Mortalitat

Subject (English)

Salmonella, Mortality

Citation

Collections

Articles publicats en revistes (ISGlobal)

Citation

BASSAT ORELLANA, Quique and GBD 2017 Non-Typhoidal Salmonella Invasive Disease Collaborators. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Infectious Diseases. 2019. ISSN 1473-3099. [consulted: 14 of June of 2026]. Available at: https://hdl.handle.net/2445/143462

Export metadata

JSON - METS

Share record